--- title: "Mounjaro Side Effects by Dose: What to Expect (2026) | GLPMate" url: https://glpmate.me/blog/mounjaro-side-effects-2026 language: en description: "Mounjaro side effects by dose from the 2026 US label: nausea, diarrhea and appetite loss at 5–15 mg, when they ease, serious warnings and when to get help." updated: 2026-10-14 --- [Blog](/blog) # Mounjaro side effects: what the label shows dose by dose, how long they last and when to call a doctor By [the GLPMate team](/editorial-policy) · Based on FDA prescribing information & peer-reviewed sources · Updated 2026-10-14 · 5 min read Quick answer In Mounjaro's placebo-controlled type 2 diabetes trials, nausea affected 12%, 15% and 18% of adults at 5, 10 and 15 mg vs 4% on placebo, with diarrhea, decreased appetite, vomiting and constipation next. Most stomach side effects happen during dose increases and fade over time. Serious but rarer risks include pancreatitis, gallbladder disease and low blood sugar with insulin or a sulfonylurea. ## What are the most common Mounjaro side effects? Mounjaro (tirzepatide) is a once-weekly injection that acts on two gut-hormone receptors, GIP and GLP-1. In the US it’s approved for **type 2 diabetes** in adults and children aged 10 and over, and to lower the risk of heart attack, stroke and cardiovascular death in adults with type 2 diabetes at high risk of these events. Its side-effect data therefore come from people with diabetes. The label’s main table pools two placebo-controlled trials (SURPASS-1 and SURPASS-5) with 718 adults on Mounjaro for an average of about 37 weeks: Side effect | Placebo | 5 mg | 10 mg | 15 mg Nausea | 4% | 12% | 15% | 18% Diarrhea | 9% | 12% | 13% | 17% Decreased appetite | 1% | 5% | 10% | 11% Vomiting | 2% | 5% | 5% | 9% Constipation | 1% | 6% | 6% | 7% Indigestion | 3% | 8% | 8% | 5% Abdominal pain | 4% | 6% | 5% | 5% Burping, gas, reflux and bloating were also more common than on placebo. Numbers vary by trial: in SURPASS-2, with adults already on metformin, nausea affected 17–22% across Mounjaro doses, and digestive events were mostly mild to moderate. **37% → 44%** Adults with any digestive side effect in Mounjaro's placebo-controlled trials, rising from 37.1% at 5 mg to 39.6% at 10 mg and 43.6% at 15 mg, vs 20.4% on placebo (US label). Stopping because of them rose with dose too, from 3.0% to 6.6%, vs 0.4% on placebo. Some groups saw a different mix. In the large heart-outcomes trial (6,647 adults with heart disease on Mounjaro), decreased appetite (17%), constipation (13%), vomiting (12%), abdominal pain (10%) and fatigue (10%) were reported more often than in the pooled trials. Children aged 10 and over had more vomiting, stomach pain and low blood sugar than adults. Taking tirzepatide for weight as Zepbound instead? Its trials differ, so see our [Zepbound side-effects guide](/blog/zepbound-side-effects-2026). ## When do Mounjaro side effects start, and how long do they last? Mounjaro starts at **2.5 mg once a week**. If more blood-sugar control is needed, the dose rises in 2.5 mg steps (5, 7.5, 10, 12.5 mg), each after at least 4 weeks, up to 15 mg in adults. Reaching 15 mg therefore takes at least 20 weeks, and every step is a fresh adjustment for your gut. The label says most nausea, vomiting and diarrhea happened **during dose escalation and decreased over time**. In practice: - The first weeks on 2.5 mg, and the week or two after each increase, are the most likely times for symptoms. - A dose that felt fine doesn’t guarantee the next one will; flares after an increase are common. - Neither the label nor the trial reports we reviewed give an average episode length for tirzepatide, so judge by trend: improving week to week is the usual pattern. If a step is hard going, ask your prescriber about staying longer at your current dose rather than adjusting it yourself. If you miss a dose, the label allows taking it within 4 days; after that, skip it and keep your usual day. ## What are the serious side effects of Mounjaro? ### Boxed warning: thyroid C-cell tumors Tirzepatide caused thyroid C-cell tumors in rats; whether it does in humans is unknown. Mounjaro must not be used if you or a family member have had medullary thyroid carcinoma or if you have MEN 2. Report a neck lump, trouble swallowing, shortness of breath or persistent hoarseness. ### Pancreatitis Confirmed acute pancreatitis occurred at 0.23 patients per 100 years of exposure on Mounjaro vs 0.11 on comparators. Severe stomach pain that won’t go away, sometimes reaching your back, means stopping Mounjaro and calling your provider right away. Mounjaro also raised pancreatic enzymes on blood tests (lipase by 31–42% on average); without symptoms, the meaning of this is unknown, so don’t be alarmed by a lab result alone. ### Low blood sugar with insulin or a sulfonylurea On its own, no readings below 54 mg/dL were reported with Mounjaro in its 40-week monotherapy trial. Added to basal insulin, lows below 54 mg/dL occurred in 14–19% vs 13% on placebo, and with a sulfonylurea in 9.9–13.8% in a trial lasting up to 104 weeks. Your prescriber may lower those medicines when you start. ### Gallbladder disease Gallstones, biliary colic or gallbladder removal were reported in 0.6% vs 0% on placebo. Watch for upper stomach pain, fever, yellowing skin or eyes and clay-colored stools. ### Kidneys, severe stomach problems and eyes Kidney injury, sometimes needing dialysis, has been reported, mostly after dehydration from vomiting or diarrhea. Severe digestive reactions occurred in 0.4–1.3% vs 0.9% on placebo, and Mounjaro isn’t recommended in severe gastroparesis. If you have diabetic retinopathy, rapid blood-sugar improvement can temporarily worsen it, so keep eye checks up to date. ### Allergy, injection sites, heart rate and anesthesia Allergic-type reactions such as hives or eczema occurred in 3.2% vs 1.7%, and serious reactions (anaphylaxis, angioedema) have been reported. Injection-site reactions were more common than on placebo (3.2% vs 0.4%). Heart rate rose by 2 to 4 beats per minute on average; the label calls the relevance uncertain. Because Mounjaro slows stomach emptying, tell every care team before surgery or sedation. Post-approval reports also include bowel blockage, severe constipation and hair loss; their frequency can’t be reliably estimated. ## What helps with Mounjaro side effects? These are covered in depth in our guides: - **Nausea:** small, low-fat meals, eaten slowly, stopping at fullness. See [GLP-1 nausea relief](/blog/glp-1-nausea-relief-2026). - **Constipation or diarrhea:** fluids, gradual fiber and daily movement. Our [constipation guide](/blog/glp-1-constipation-relief-2026) covers when to ask about laxatives. - **Low appetite:** decreased appetite is a listed side effect, so make small meals count with protein first; see [what to eat on a GLP-1](/blog/what-to-eat-on-glp-1-2026). If you use insulin or a sulfonylurea, ask what to do on days you barely eat. - **Alcohol:** it adds to nausea and, with diabetes medicines, to the risk of lows; read [alcohol and GLP-1 medicines](/blog/alcohol-and-glp-1-2026). - **Hair shedding:** our [hair loss guide](/blog/glp-1-hair-loss-2026) explains why it often follows weight loss. - **The pill:** if you use oral contraception, the label advises switching to a non-oral method or adding a barrier method for 4 weeks after starting and after each dose increase. See [birth control and pregnancy on GLP-1s](/blog/glp-1-birth-control-pregnancy-2026). ## When should you call your doctor about Mounjaro side effects? Seek urgent care for: - Severe stomach pain that won’t go away, with or without vomiting - Vomiting or diarrhea that stops you keeping fluids down, or very little urine - Swelling of the face, lips, tongue or throat, or trouble breathing - Upper stomach pain with fever or yellowing skin or eyes - A low blood sugar that doesn’t respond to treatment Book a regular visit if side effects last weeks at one dose, your vision changes, you notice a neck lump, or you’re planning surgery or a pregnancy. ## What should you log on Mounjaro? Because side effects track dose so closely, pair every note with your current step: - Dose, date and injection site - Each symptom with a severity rating, and days since the last increase - Blood sugar readings, especially lows if you also use insulin or a sulfonylurea - Meals and fluids on low-appetite days - Injection-site redness or itching GLPMate’s [Mounjaro tracker](/mounjaro-tracker-app) logs doses with reminders and site rotation, and the [side-effect log](/glp-1-side-effect-tracker) records severity against each dose step; the doctor report turns it into a PDF for your next appointment. This article is educational only and not medical advice. Talk to your doctor about any side effect that worries you. FAQ ## FAQ ### What are the most common side effects of Mounjaro? Digestive ones. In the label's placebo-controlled diabetes trials, nausea affected 12–18% of adults depending on dose (vs 4% on placebo), diarrhea 12–17% (vs 9%), decreased appetite 5–11% (vs 1%), vomiting 5–9% (vs 2%) and constipation 6–7% (vs 1%). Indigestion and stomach pain were also more common. ### Do Mounjaro side effects get worse at higher doses? Generally yes. Any digestive side effect rose from 37.1% at 5 mg to 39.6% at 10 mg and 43.6% at 15 mg (vs 20.4% on placebo), and stopping because of them rose from 3.0% to 6.6% (vs 0.4%). That's why doses go up in 2.5 mg steps, each after at least 4 weeks. ### How long do Mounjaro side effects last? The label says most nausea, vomiting and diarrhea happened during dose escalation and decreased over time, so each step up can bring a short flare that settles. The label doesn't give an average duration. If symptoms persist for weeks at the same dose, or you can't keep fluids down, contact your prescriber. ### Does Mounjaro affect birth control pills? It can. Mounjaro slows stomach emptying, so the label advises people on oral hormonal contraceptives to switch to a non-oral method or add a barrier method for 4 weeks after starting and for 4 weeks after each dose increase. Non-oral hormonal methods shouldn't be affected; check your plan with your prescriber. ## Sources 1. MOUNJARO (tirzepatide) injection, US Prescribing Information and Medication Guide, Eli Lilly — revised August 2026 (DailyMed) — indications incl. CV risk reduction; 2.5 mg start, 2.5 mg steps after at least 4 weeks, maximum 15 mg (adults) and 10 mg (age 10+); Table 1 by dose; GI 37.1%/39.6%/43.6% vs 20.4%, GI discontinuation 3.0%/5.4%/6.6% vs 0.4%, mostly during escalation and decreasing over time; CV outcomes trial and pediatric differences; hypoglycemia tables; heart rate, hypersensitivity, injection-site, gallbladder, pancreatitis and enzyme data; boxed warning and warnings; oral contraceptive advice; missed dose within 4 days; postmarketing reports 2. Frías et al., NEJM 2021 (SURPASS-2) — tirzepatide 5, 10, 15 mg vs semaglutide 1 mg, 40 weeks, 1,879 adults with type 2 diabetes on metformin — GI events most common and primarily mild to moderate; nausea 17–22% with tirzepatide; hypoglycemia below 54 mg/dL in 0.2–1.7% 3. Lilly Medical Information — incidence and severity of GI adverse events in the SURPASS program — most nausea, vomiting and diarrhea mild to moderate and during the 20-week escalation period, decreasing with continued use Sources checked: October 14, 2026 This article is educational and is not medical advice, diagnosis or treatment. Medication decisions — including dose changes and what to do after a missed dose — belong with your prescriber. If you experience severe symptoms, seek medical care. ## Keep reading [Mounjaro tracker app ](/mounjaro-tracker-app)[Log side effects and severity ](/glp-1-side-effect-tracker)[GLP-1 constipation relief ](/blog/glp-1-constipation-relief-2026) ## Start your GLP-1 journey with a companion that listens. Free to start. iOS & Android. [ Download on the **App Store** ](https://glpmate.go.link?adj_t=22klhq12&adj_campaign=blog-mounjaro-side-effects-2026&adj_redirect_android=https%3A%2F%2Fapps.apple.com%2Fapp%2Fid6788548235&adj_redirect_macos=https%3A%2F%2Fapps.apple.com%2Fapp%2Fid6788548235&adj_redirect_windows=https%3A%2F%2Fapps.apple.com%2Fapp%2Fid6788548235) [ GET IT ON **Google Play** ](https://glpmate.go.link?adj_t=22klhq12&adj_campaign=blog-mounjaro-side-effects-2026&adj_redirect_ios=https%3A%2F%2Fplay.google.com%2Fstore%2Fapps%2Fdetails%3Fid%3Dapp.eleutheromania.glpmate&adj_redirect_macos=https%3A%2F%2Fplay.google.com%2Fstore%2Fapps%2Fdetails%3Fid%3Dapp.eleutheromania.glpmate&adj_redirect_windows=https%3A%2F%2Fplay.google.com%2Fstore%2Fapps%2Fdetails%3Fid%3Dapp.eleutheromania.glpmate)